HSA Approval

EYLEA SOLUTION FOR INJECTION 114.3 MG/ML

Approval Number

SIN17040P

Drug Name

Product Name

EYLEA SOLUTION FOR INJECTION 114.3 MG/ML

Approval Date

July 5, 2024

Registrant

BAYER (SOUTH EAST ASIA) PTE LTD

Regulatory Information

Registrant

BAYER (SOUTH EAST ASIA) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVITREOUS

Medical Information

ATC Code

S01LA05

Manufacturer Information

Pharmaceutical Manufacturer

BAYER (SOUTH EAST ASIA) PTE LTD

Manufacturers

Catalent Indiana, LLC

Active Ingredients

Ingredient Name

Aflibercept

Strength

114.3mg/ml

Drug MonographAflibercept

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

EYLEA SOLUTION FOR INJECTION 114.3 MG/ML - HSA Approval | MedPath

AI-Powered Research

Premium Access

EYLEA SOLUTION FOR INJECTION 114.3 MG/ML

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal